tiprankstipranks
Trending News
More News >
Ramm Pharma (TSE:RAMM)
:RAMM
Canadian Market

Ramm Pharma (RAMM) Income Statement

Compare
1 Followers

Ramm Pharma Income Statement

Last quarter (Q1 2025), Ramm Pharma's total revenue was C$1.01M, an increase of 5.75% from the same quarter last year. In Q1, Ramm Pharma's net income was C$-1.02M. See Ramm Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 4.34MC$ 5.07MC$ 3.90MC$ 4.12MC$ 5.44M
Gross Profit
C$ 1.76MC$ 381.82KC$ 530.50KC$ -7.64KC$ 1.28M
Operating Expenses
C$ 8.52MC$ 7.47MC$ 8.46MC$ 6.63MC$ 8.86M
Depreciation and Amortization
C$ 1.21MC$ 1.34MC$ 1.02MC$ 732.63KC$ 461.26K
EBITDA
C$ -15.23MC$ -6.30MC$ -19.91MC$ -6.36MC$ -6.91M
Operating Income
C$ -6.76MC$ -7.09MC$ -7.93MC$ -7.19MC$ -7.58M
Other Income/Expenses
C$ -9.73MC$ -625.08KC$ -13.02MC$ 92.01KC$ 150.13K
Pretax Income
C$ -16.49MC$ -7.71MC$ -20.95MC$ -7.10MC$ -7.43M
Net Income
C$ -16.50MC$ -7.72MC$ -20.96MC$ -7.11MC$ -7.43M
Per Share Metrics
Basic EPS
C$ -0.14C$ -0.06C$ -0.17C$ -0.07C$ -0.07
Diluted EPS
C$ -0.14C$ -0.06C$ -0.17C$ -0.07C$ -0.07
Weighted Average Shares Outstanding
119.39M 121.04M 122.77M 108.46M 100.56M
Weighted Average Shares Outstanding (Diluted)
119.39M 121.04M 122.77M 108.46M 100.56M
Currency in CAD

Ramm Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis